$2.34 0.09 (+4.00%)
11/25/2009 4:00 PM

DURECT Corp (DRRX)

CAPS Rating: 3 out of 5

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

Featured Broker Partners